BioPharmGuy logo
Sponsored By:
Project Management Now
Purchase the BioPharmGuy data
Sinclair Research
Tensha Therapeutics is defunct.

Fate: Acquired by Roche, Jan 2016, $115M + $420 Milestones


------------------
If you believe any of this information is incorrect, please let us know.